ABBOTT LABORATORIES — Director's Dealing 2014

Jun 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-06-03

Reporting Person: Landgraf John C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-03	Common shares without par value	M	6247	$31.4255	Acquired	101378	Direct
2014-06-03	Common shares without par value	M	11956	$32.1559	Acquired	113334	Direct
2014-06-03	Common shares without par value	F	16284	$39.80	Disposed	97050	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-03	Option (right to buy)	$31.4255	M	6247	Disposed	2014-08-02	Common shares (6247)	Direct
2014-06-03	Option (right to buy)	$32.1559	M	11956	Disposed	2014-08-02	Common shares (11956)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	18673	Indirect
Common shares without par value	168	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of June 3, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his son.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.